Literature DB >> 2441732

Carbohydrate antigen 19-9 as a serum marker of hepatocellular carcinoma: comparison with alpha-foetoprotein.

M C Kew, E L Berger, H Koprowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2441732      PMCID： PMC2001680          DOI： 10.1038/bjc.1987.160

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  5 in total

1.  The value of serum concentrations of tissue polypeptide antigen in the diagnosis of hepatocellular carcinoma.

Authors:  M C Kew; E L Berger
Journal:  Cancer       Date:  1986-07-01       Impact factor: 6.860

2.  Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.

Authors:  M K Gupta; R Arciaga; L Bocci; R Tubbs; R Bukowski; S D Deodhar
Journal:  Cancer       Date:  1985-07-15       Impact factor: 6.860

Review 3.  Alpha-fetoprotein in primary liver cancer and other diseases.

Authors:  M Kew
Journal:  Gut       Date:  1974-10       Impact factor: 23.059

4.  Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.

Authors:  H Jalanko; P Kuusela; P Roberts; P Sipponen; C A Haglund; O Mäkelä
Journal:  J Clin Pathol       Date:  1984-02       Impact factor: 3.411

5.  Gastrointestinal cancer-associated antigen in immunoperoxidase assay.

Authors:  B F Atkinson; C S Ernst; M Herlyn; Z Steplewski; H F Sears; H Koprowski
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701
  5 in total
  1 in total

1.  The role of carbohydrate antigen 19-9 as a tumour marker of oesophageal cancer.

Authors:  A McKnight; A Mannell; I Shperling
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.